Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/138685
DC FieldValue
dc.titleMODULATING T CELL RECEPTOR SIGNALLING IN RESPONSE TO SUBOPTIMAL AGONIST PEPTIDE-MHC COMPLEX
dc.contributor.authorZHAO XIANG
dc.date.accessioned2018-01-31T18:01:21Z
dc.date.available2018-01-31T18:01:21Z
dc.date.issued2017-08-22
dc.identifier.citationZHAO XIANG (2017-08-22). MODULATING T CELL RECEPTOR SIGNALLING IN RESPONSE TO SUBOPTIMAL AGONIST PEPTIDE-MHC COMPLEX. ScholarBank@NUS Repository.
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/138685
dc.description.abstractThere are lots of instances where the agonist signal is suboptimal. In this thesis, several strategies and gene functions have been studied to try to optimize T cell responses to suboptimal agonists by modulating T cell receptor signalling. The first part is to study coagonism in human T cells. We found that non-stimulatory-peptide-MHC could be used as coagonist to enhance human T cell response to HBV antigens. Coagonism in human T cell required CD8 binding but not TCR binding to the coagonist pMHC. The second part of the thesis focus on a gene called Themis in regulating TCR signalling strength. There is quite high-level expression of Themis in mature T cells. We found that the TCR signalling strength might not be largely affected in Themis conditional knockout mice lymphocytes, but there is less cytokine production. There are also more TCR downregulation in Themis conditional knockout lymphocytes.
dc.language.isoen
dc.subjectTCR, peptide, MHC, signalling, coagonism, Themis
dc.typeThesis
dc.contributor.departmentMICROBIOLOGY & IMMUNOLOGY
dc.contributor.supervisorNICHOLAS ROBERT JOHN GASCOIGNE
dc.description.degreePh.D
dc.description.degreeconferredDOCTOR OF PHILOSOPHY
Appears in Collections:Ph.D Theses (Open)

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
ZhaoX.pdf11.57 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.